Versuchen GOLD - Frei
Where growth comes from
Business Standard
|October 20, 2025
This year’s Nobelists argue that countries grow only when their policies embrace pragmatism and their cultures seek progress
What is economic growth, and from what does it emerge? Is it simply an accumulation of more material, more inputs, more natural resources, and more labour and capital? Is it a product basically of technological progress, or is there something even more subtle at work?
That should be a core question for the discipline of economics, but surprisingly few Nobel Prizes have been awarded to those who ask it. When Joel Mokyr, Philippe Aghion, and Peter Howitt were given the prize this year, they joined a very short list. Only Simon Kuznets in 1971 and Robert Solow in 1987 have been explicitly rewarded for their work on the theory and accounting of growth.
Kuznets is remembered most for his observation that inequality within an economy initially increases with growth, and then decreases — the “inverted-U” curve that bears his name. But this observation is actually a subset of his broader insight that growth is never simple, but contains within it an enormous restructuring of the productive relations within any economy undergoing it. And, as head of the United States’ National Bureau of Economic Research’s project on national income accounting, he advanced more than anyone the concept of a “gross domestic product” (GDP) that is so ubiquitous today.
Solow, meanwhile, created the relatively simple model that underlies how all GDP growth today is measured and analysed. GDP is created by combinations of inputs — capital and labour, primarily. If you chose to save and invest, you grew faster. When put together with labour-enhancing technological progress, the Solow model shows the growth rate of output per worker is determined essentially by the rate of technological change.
Diese Geschichte stammt aus der October 20, 2025-Ausgabe von Business Standard.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Business Standard
Business Standard
FD left without a Will? Here's how children, grandchildren can claim money
Fixed deposits (FDs) are a common savings tool across Indian households.
1 min
February 14, 2026
Business Standard
Reliance gets US licence to directly buy Venezuela oil
Private-sector oil refiner Reliance Industries Limited (RIL) last week received a general licence from the United States (US) government to buy Venezuelan oil, an industry executive told Business Standard.
1 mins
February 14, 2026
Business Standard
Torrent Pharma profit rises 26%
Ahmedabad-based Torrent Pharmaceuticals on Friday posted a 26 per cent year-on-year (Y-0-Y) increase in net profit on a consolidated basis for the third quarter of the financial year (Q3FY26) to %635 crore. The revenue from operations also grew 17.6 per cent to %3,303 crore.
1 min
February 14, 2026
Business Standard
Delhi-Dhaka ties may warm up after BNP’s win
But stronger Jamaat a concern
2 mins
February 14, 2026
Business Standard
Friday the 13th caps a week of AI-sparked horror in IT stocks
Top software exporters suffer nearly ₹5 trn mcap loss as rout deepens
2 mins
February 14, 2026
Business Standard
BEE may rationalise technology credits
The Bureau of Energy Efficiency (BEE) is planning to rationalise the list of technologies that carmakers can classify as \"fuel-saving\" to claim \"technology derogation credits\" while calculating the average emission of carbon dioxide in a fleet of vehicles, Business Standard has learnt.
2 mins
February 14, 2026
Business Standard
Leverage, time & the long game
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they'd seen marginal interest. The starkest example is India and Europe
5 mins
February 14, 2026
Business Standard
‘Biopharma Shakti shows India focusing on being biopharma hub’
Fresh from a reduction in debt and a capital raise of $1 billion, Biocon Ltd is sharpening its focus on biosimilars, GLP-1s (glucagon-like peptide-1s), and manufacturing on a global scale. In a video interaction with Sohini Das, Biocon Group Chairperson Kiran Mazumdar-Shaw explains how lower borrowing costs will lift profitability, and why regulatory reform and adopting artificial intelligence (AI) are critical for India to be a biopharma hub. Edited excerpts:
3 mins
February 14, 2026
Business Standard
Munich Conference: German Chancellor calls for reset with US as old global order crumbles
German Chancellor Friedrich Merz on Friday called for a stronger Europe to reset its ties with the United States, wanting Washington to “repair and revive trust” in a dangerous new era of great power politics as the old global order crumbles.
1 mins
February 14, 2026
Business Standard
₹70 lakh for 10 secs: India-Pak clash sends ad rates over the ropes
Days after Pakistan backtracked on its earlier decision to boycott the marquee showdown with India at the ongoing ICC Men's T20 World Cup, the commercial upswing following that clarity is already visible.
2 mins
February 14, 2026
Listen
Translate
Change font size
